日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth
Celaid Therapeutics Inc. announced that it successfully completed the first close of…
Panasonic Launches Facial Analysis Tool for Brain Health
Panasonic Holdings unveiled its "Estimated BHQ" system, a novel brain health measurement…
Gunze Medical signs Japan distribution deal with HistoSonics
Gunze Limited, based in Osaka, Japan, announced that its subsidiary, Gunze Medical…
Olympus Launches SecureFlex Single-Use Biopsy Device
Olympus Corporation has launched SecureFlex. This is a single-use fine needle biopsy…
Rentschler Biopharma Expands in Japan and Korea
Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…
Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer
Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…
Japan’s Digital Therapeutics Market Poised for Takeoff — What It Means for Tech Players
Japan is quietly becoming one of Asia’s most promising frontiers for digital…
Doctors and Nankodo Form Alliance for AI Medical Platform
Doctors, Inc., a leading provider of comprehensive digital health solutions from service…
Latest Article
English